Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sai Harsha Bobba"'
Autor:
Muhammad Areeb Iqbal, Shanthi Potla, Kim Andrews, Raza Zarrar, Marc-Darlene Mezidor, Anusha Sajja, Endrit Shahini, Thiruvengadam Muniraj, Faiza Ahmed, Aysha Aslam, Zeynep Yukselen, Sai Harsha Bobba, Israr Khan, Sarfraz Ahmad, Karthik Mohan
Publikováno v:
American Journal of Gastroenterology. 116:S1340-S1342
Autor:
Maria Kezia Pormento, Sivasthikka Lingarajah, Rajni Gautam, Molly Jain, Ravi Jagani, Nicky Jagani, Ngaba Ngardig, Sai Harsha Bobba, Klodin Ghazarian, Sukrut Pagad
Publikováno v:
Endocrine Practice. 27:S6-S7
Autor:
Namrata Hange, Manoj Reddy Somagutta, Atul Wadagale, Alaa Hassan Yousif Hamdan, Molly Sanjay Jain, Sai Harsha Bobba, Erkan Batti, Bernard Emuze
Publikováno v:
Electronic Journal of General Medicine. 19:em372
Autor:
Molly Jain, Gouthami Sajjanagandla, Klodin Ghazarian, Sai Harsha Bobba, Ngaba Ngardig, Sivasthikka Lingarajah, Jaspreet Kaur, Rajni Gautami, Sukrut Pagad, Maria Kezia Pormento, Michael Jutovsky
Publikováno v:
Endocrine Practice. 27:S8
Autor:
Faiza Zakaria, Ammu Susheela, Faiza Ahmed, Thiruvengadam Muniraj, Shanthi Potla, Sai Harsha Bobba, Aysha Aslam, Karthik Mohan, Ujala Nasr, Kim Andrews, Raza Zarrar, Alaa Hamdan, Marc-Darlene Mezidor, Zeynep Yukselen, Anusha Sajja, Endrit Shahini, Sarfraz Ahmad
Publikováno v:
American Journal of Gastroenterology. 116:S272-S272
Autor:
Sai Harsha Bobba, Ujala Nasr, Aysha Aslam, Shanthi Potla, Zeynep Yukselen, Marc-Darlene Mezidor, Faiza Ahmed, Alaa Hamdan, Anusha Sajja, Kim Andrews, Thiruvengadam Muniraj, Faiza Zakaria, Raza Zarrar, Sundus Ali, Endrit Shahini, Karthik Mohan, Ammu Susheela
Publikováno v:
American Journal of Gastroenterology. 116:S51-S51
Autor:
Bernard O Emuze, Namrata Hange, Narayana Reddy Bathula, Erkan Batti, Manoj R Somagutta, Ulhas Vasave, Obumneme Jude Iloeje, Gouthami Sajjanagandla, Klodin Ghazarian, Sai Harsha Bobba
Publikováno v:
International Journal Of Community Medicine And Public Health. 8:4605
Gastric cancer is one of the most common and deadliest cancers known globally. Due to historically low survival rates and available few treatment modalities, especially in developing nations with high burden incidence of gastric cancers, reducing inc